Arcus Biosciences, Inc. (RCUS)

USD 15.17

(-5.66%)

Inventory Summary of Arcus Biosciences, Inc.

  • Arcus Biosciences, Inc.'s latest annual inventory in 2023 was - USD , up 100.0% from previous year.
  • Arcus Biosciences, Inc.'s latest quarterly inventory in 2024 Q1 was - USD , down 0.0% from previous quarter.
  • Arcus Biosciences, Inc. reported annual inventory of -172 Million USD in 2022, up 77.44% from previous year.
  • Arcus Biosciences, Inc. reported annual inventory of -762.44 Million USD in 2021, down -10535.26% from previous year.
  • Arcus Biosciences, Inc. reported quarterly inventory of - USD for 2024 Q2, down 0.0% from previous quarter.
  • Arcus Biosciences, Inc. reported quarterly inventory of -207 Million USD for 2023 Q3, down -158.75% from previous quarter.

Annual Inventory Chart of Arcus Biosciences, Inc. (2023 - 2016)

Historical Annual Inventory of Arcus Biosciences, Inc. (2023 - 2016)

Year Inventory Inventory Growth
2023 - USD 100.0%
2022 -172 Million USD 77.44%
2021 -762.44 Million USD -10535.26%
2020 -7.16 Million USD 0.0%
2019 - USD 0.0%
2018 - USD 0.0%
2017 - USD 0.0%
2016 - USD 0.0%

Peer Inventory Comparison of Arcus Biosciences, Inc.

Name Inventory Inventory Difference
ADC Therapeutics SA 16.17 Million USD 100.0%
Alto Neuroscience, Inc. - USD NaN%
Annovis Bio, Inc. - USD NaN%
Biohaven Pharmaceutical Holding Company Ltd. - USD NaN%
Ginkgo Bioworks Holdings, Inc. 46 Thousand USD 100.0%
Nuvation Bio Inc. - USD NaN%
Nuvation Bio Inc. - USD NaN%
Theriva Biologics, Inc. - USD NaN%
Zymeworks Inc. 1.00 USD 100.0%